Drug Trial Radar · NCT03996291
Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis
Last checked: Nov 20, 2026Latest source record: Oct 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
125
Actual
Start
Sep 23, 2019
Primary completion
Nov 26, 2024
Study completion Nov 26, 2024
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jun 24, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: To determine the long-term safety and tolerability of SAR442168 in RMS participants Secondary Objective: To evaluate efficacy of SAR442168 on disease activity, assessed by clinical and imaging methods
Conditions
- Relapsing Multiple Sclerosis
Interventions
TolebrutinibDrug
Pharmaceutical form: Film coated tablet Route of administration: Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs)Time frame: From first dose of study drug (Day 1) up to maximum exposure, 39 weeks in Part A and 222 weeks in Part B
Locations
37 sites in 9 countries. Site status is shown where the registry gives one.
North Central Neurology Associates, PC Site Number : 8400005
Cullman, Alabama
Neurology Associates, PA Site Number : 8400002
Maitland, Florida
University of South Florida Site Number : 8400009
Tampa, Florida
Velocity Clinical Research Site Number : 8400007
Savannah, Georgia
Consultants In Neurology Site Number : 8400001
Northbrook, Illinois
UC Health, LLC Site Number : 8400008
Dayton, Ohio
MDH Research LLC Site Number : 8400006
Westerville, Ohio
Neurology PC Site Number : 8400003
Knoxville, Tennessee
Investigational Site Number : 1240003
Vancouver, British Columbia, Canada
Investigational Site Number : 1240001
Greenfield Park, Quebec, Canada
Investigational Site Number : 2030007
Brno, Czechia
Investigational Site Number : 2030004
Hradec Králové, Czechia
Investigational Site Number : 2030003
Jihlava, Czechia
Investigational Site Number : 2030005
Ostrava - Poruba, Czechia
Investigational Site Number : 2030006
Pardubice, Czechia
Investigational Site Number : 2030001
Prague, Czechia
Investigational Site Number : 2030002
Praha 5 - Motol, Czechia
Investigational Site Number : 2330001
Tallinn, Estonia
Investigational Site Number : 2500004
Nancy, France
Investigational Site Number : 5280001
Amsterdam, Netherlands
Investigational Site Number : 6430006
Kazan', Russia
Investigational Site Number : 6430003
Moscow, Russia
Investigational Site Number : 6430005
Saint Petersburg, Russia
Investigational Site Number : 6430001
Saint Petersburg, Russia
Investigational Site Number : 6430007
Tyumen, Russia
Investigational Site Number : 7240001
Madrid, Spain
Investigational Site Number : 7240004
Murcia, Spain
Investigational Site Number : 7240003
Seville, Andalusia, Spain
Investigational Site Number : 7240002
Barcelona, Barcelona [Barcelona], Spain
Investigational Site Number : 7240005
Salt, Girona [Gerona], Spain
Investigational Site Number : 8040002
Chernivtsi, Ukraine
Investigational Site Number : 8040005
Dnipro, Ukraine
Investigational Site Number : 8040001
Lviv, Ukraine
Investigational Site Number : 8040006
Lviv, Ukraine
Investigational Site Number : 8040009
Odesa, Ukraine
Investigational Site Number : 8040003
Vinnytsia, Ukraine
Investigational Site Number : 8040007
Zhytomyr, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.